The Genetics of Heart & Vascular Disease

October 10-12, 2019
The Meritage Resort, Napa, CA

Registration Closed
Credit Types: AMA PRA Category 1 (15.75), MOC (15.75), | Price: $575-$700 | Early Registration $100 Off


The Meritage Resort and Spa
875 Bordeaux Way
Napa, CA 94558

The Meritage Resort and Spa room block is sold out.  We recommend you book a room through TripAdvisor - the Vino Bello hotel is connected to The Meritage.  Others are close by.

During this 3 day CME course, experts in the field of cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of diseases affecting the heart and the blood vessels.

Topics covered will include, Genetics Genomics 101, pharmacogenetics, polygenic risk scores, variant interpretation, the molecular autopsy, and the diagnostic, prognostic, & therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, cardiac amyloid, and the aortopathies.

Unique Features:  Audience response system to enhance immediate feedback.  Easy access to faculty members.  One-on-one interaction.  Efforts will be made to introduce the clinical applications using new technology, however, there is no hands-on experience provided.  Self-assessment questions to gauge outcome.  A special workshop will be conducted to analyze a genetic test report and to comment on the significance of genetic test results from your patients.

To reinforce the knowledge gained from the course and ensure lasting value to each attendee’s practice, Mayo Clinic provides access to all course presentations with voice-over recordings after the completion of the course.

Upon conclusion of this program, participants should be able to:

  • • Summarize the probabilistic nature of genetic testing and develop a strategy to manage the variant of uncertain significance (VUS) test result
  • • Identify the impact of genetic testing in the diagnosis, risk stratification, and treatment of patients with heritable cardiomyopathies, channelopathies, pulmonary hypertension, cardiac amyloidosis, and aortopathies
  • • Determine the role of genetic testing in children and adults with congenital heart disease
  • • Define genetic markers of atherosclerosis and the role of genetic risk scores (GRS) in risk stratification of coronary heart disease
  • • Identify the genetic basis of heritable lipid disorders and implications for prevention and familial screening
  • • Define the role of genetics in cardiovascular drug response and to utilize genetics to minimize adverse events and maximize drug efficacy

This course is intended for both pediatric and adult cardiologists, internists, primary care providers, and pharmacists, and nurse practitioners with special interest in the management of patients with genetic heart and vascular disease, pediatric and adult cardiology trainees, PAs and genetic counselors with an interest in genetic cardiovascular medicine.

  • AMA PRA Category 1™
  • MOC

Price: $575-$700 | Early Registration $100 Off

Live Courses

Back to Top